bpc 157 ufc BPC-157 UFC 157 - Wikipedia

The same 500mcg via nasal spray delivers roughly 200-300mcg systemically

What FDA has said recently (high-level, patient-friendly summary) FDA maintains a page describing certain bulk drug substances used in compounding that may present significant safety risks, including AOD-9604, noting concerns such as potential immunogenicity and limited safety-related information for some uses/routes

This process separates the different components of the blood, isolating the platelet-rich plasma (PRP) that contains the concentrated healing factors used for treatment

Patients who had been enabled to self-treat over the pandemic embraced the change to their treatment and preferred this to standard treatment